VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · Real-Time Price · USD
0.6050
+0.0049 (0.82%)
Sep 26, 2025, 4:00 PM EDT - Market closed
VolitionRx Employees
VolitionRx had 85 employees as of December 31, 2024. The number of employees decreased by 25 or -22.73% compared to the previous year.
Employees
85
Change (1Y)
-25
Growth (1Y)
-22.73%
Revenue / Employee
$15,521
Profits / Employee
-$274,385
Market Cap
65.10M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
VNRX News
- 18 days ago - Volition Signs First Human Out Licensing Deal - PRNewsWire
- 6 weeks ago - VolitionRx Limited (VNRX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - VolitionRx Limited Announces Second Quarter 2025 Financial Results and Business Update - PRNewsWire
- 7 weeks ago - VolitionRx Limited Schedules Second Quarter 2025 Earnings Conference Call and Business Update - PRNewsWire
- 7 weeks ago - VolitionRx Announces Pricing of $1.2 Million Registered Direct Offering - PRNewsWire
- 2 months ago - Nu.Q® Discover Expands Global Adoption and Epigenetic Innovation - PRNewsWire
- 2 months ago - Volition Announces Groundbreaking Lateral Flow Test for Point-of-Care Quantification of Nucleosomes - PRNewsWire
- 3 months ago - Volition Announces MARS Consortium Clinical Study Suggests Nu.Q® H3.1. Concentrations are Closely Associated with Sepsis and Organ Failure - PRNewsWire